Aug 26, 2021: Humacyte, Inc, a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today announced the successful completion of its business combination with Alpha Healthcare Acquisition Corp.
AHAC IPO
Sep 18, 2020: Alpha Healthcare Acquisition Corp. announced that it priced its initial public offering of 10,000,000 units at $10.00 per unit.